Johnson & Johnson today announced that the company has submitted the OTTAVAâ„¢ Robotic Surgical System to the U.S. Food and Drug Administration (FDA) in an application for De Novo classification.
Abstract: The ever-expanding volume of scientific literature necessitates innovative solutions for efficient information organization and retrieval. This final qualifying work focuses on the ...